Ginkgo Bioworks Holdings, Inc. (the “Company”) is aware of the closure of Silicon Valley Bank (“SVB”) and appointment of the Federal Deposit Insurance
Corporation as receiver. Only the cash balance of the Company’s wholly-owned subsidiary Zymergen Inc. is held in deposit accounts at SVB, representing
approximately $74 million or 6% of the Company’s cash and cash equivalents as of December 31, 2022. The Company does not maintain any other material
accounts or lines of credit with SVB.
Ginkgo Bioworks Holdings, Inc. (the “Company”) is aware of the closure of Silicon Valley Bank (“SVB”) and appointment of the Federal Deposit Insurance
Corporation as receiver. Only the cash balance of the Company’s wholly-owned subsidiary Zymergen Inc. is held in deposit accounts at SVB, representing
approximately $74 million or 6% of the Company’s cash and cash equivalents as of December 31, 2022. The Company does not maintain any other material
accounts or lines of credit with SVB.
↑DNAは74M SVBにある